Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-20-048659

Director bought 4,125 shares at an average $3.35 ($13,818)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Galante Joseph C Director 2020-06-12 Purchase +225 $3.37 $758 20,992 D
Galante Joseph C Director 2020-06-19 Purchase +375 $3.41 $1,279 21,367 D
Galante Joseph C Director 2020-06-26 Purchase +375 $3.37 $1,264 21,742 D
Galante Joseph C Director 2020-07-02 Purchase +300 $3.34 $1,002 22,042 D
Galante Joseph C Director 2020-07-10 Purchase +375 $3.31 $1,241 22,417 D
Galante Joseph C Director 2020-07-17 Purchase +375 $3.29 $1,234 22,792 D
Galante Joseph C Director 2020-07-24 Purchase +375 $3.33 $1,249 23,167 D
Galante Joseph C Director 2020-07-31 Purchase +375 $3.26 $1,223 23,542 D
Galante Joseph C Director 2020-08-07 Purchase +375 $3.42 $1,283 23,917 D
Galante Joseph C Director 2020-08-14 Purchase +375 $3.44 $1,290 24,292 D
Galante Joseph C Director 2020-08-21 Purchase +375 $3.35 $1,256 24,667 D
Galante Joseph C Director 2020-08-26 Purchase +225 $3.29 $740 24,892 D
Open-market purchases · 4,125 sh · avg $3.35 · $13,818
Loading xslF345X03/doc4.xml…